Ledger.Open graph →
SEC Form D · filed March 16, 2022

Lindy Biosciences, Inc

Offering
$5.0M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Research Triangle Park, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Karen Levert · Durham, NCDirectorOmar Flores · Research Triangle Park, NCDirectorDeborah Bitterfield · Durham, NCExec · Director · PromoterSreekar Gadde · Research Triangle Park, NCDirectorKaren Levert · Durham, NCDirectorOmar Flores · Research Triangle Park, NCDirectorDeborah Bitterfield · Durham, NCExec · Director · PromoterSreekar Gadde · Research Triangle Park, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗